DOM-LOPERAMIDE HYDROCHLORIDE SOLUTION-ORL .2 MG
LOPERAMIDE HYDROCHLORIDE : .2 MG · DIN 02138301 · DOMINION PHARMACAL
Health Canada status: CANCELLED POST MARKET
What is DOM-LOPERAMIDE HYDROCHLORIDE SOLUTION-ORL?
DOM-LOPERAMIDE HYDROCHLORIDE SOLUTION-ORL .2 MG contains LOPERAMIDE HYDROCHLORIDE : .2 MG. It is listed in the Health Canada Drug Product Database under DIN 02138301, held by DOMINION PHARMACAL, supplied as SOLUTION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 22-May-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is DOM-LOPERAMIDE HYDROCHLORIDE SOLUTION-ORL called?
The same molecule, LOPERAMIDE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Gastrex | Latin | Australia |
| Gastron | Latin | South Africa |
| A-WON DIARRHOEA RELIEF CAPSULES | Latin | Australia |
| Gastro-Stop | Latin | Australia |
| Imodium | Latin | Morocco, South Africa |
| STADIAR | Latin | Morocco |
| LOPERIUM | Latin | Morocco |
| LORASEC | Latin | Morocco |
| Pharmacy Action Diarrhoea Relief | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02138301 |
|---|---|
| Brand name | DOM-LOPERAMIDE HYDROCHLORIDE SOLUTION-ORL |
| Generic / active ingredient | LOPERAMIDE HYDROCHLORIDE : .2 MG |
| Manufacturer | DOMINION PHARMACAL |
| Strength | .2 MG |
| Dosage form | SOLUTION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07DA03 LOPERAMIDE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 22-May-2019 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02138301 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2138301 |
| Brand name | DOM-LOPERAMIDE HYDROCHLORIDE SOLUTION-ORL |
| Active ingredient / INN | LOPERAMIDE HYDROCHLORIDE : .2 MG |
| ATC code | A07DA03 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A07 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | DOMINION PHARMACAL |
Which pack is which?
| Strength on the label | .2 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A07DA03 LOPERAMIDE. 14 of 39 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DIARRHEA RELIEF | 2 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02248994 |
| DIARRHEA RELIEF | 2 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02256452 |
| DIARRHEA RELIEF FAST DISSOLVE | 2 MG | TABLET (ORALLY DISINTEGRATING) | JUNO OTC INC | MARKETED | DIN 02499517 |
| DIARRHEA RELIEF LIQUID GELS | 2 MG | CAPSULE | LABORATOIRE RIVA INC. | MARKETED | DIN 02552337 |
| DIARRHEA RELIEF LIQUID GELS | 2 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02553139 |
| IMODIUM CALMING LIQUID | 2 MG / 15 ML | SOLUTION | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02291800 |
| IMODIUM LIQUI-GELS | 2 MG | CAPSULE | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02376016 |
| IMODIUM QUICK DISSOLVE | 2 MG | TABLET (ORALLY DISINTEGRATING) | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02230542 |
| JAMP LOPERAMIDE | 2 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02544989 |
| LOPERAMIDE-2 | 2 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02225182 |
Who else supplies LOPERAMIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LOPERAMIDE appears in 37 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does LOPERAMIDE cost around the world?
LOPERAMIDE is listed on 10 national price registers Nexara tracks, across 60 pack listings published on 9 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 2 | 25 | 03 Sep 2026 |
| Australia | ex-manufacturer | 4 | 9 | 08 Sep 2026 |
| Luxembourg | reimbursement | 7 | 7 | 05 Sep 2026 |
| Morocco | PPV (public price) | 4 | 5 | 05 Sep 2026 |
| Saudi Arabia | public | 3 | 4 | 01 Sep 2026 |
| South Africa | single exit price | 2 | 4 | 01 Sep 2026 |
| Austria | KVP (Kassenverkaufspreis) | 1 | 2 | 03 Sep 2026 |
| United Kingdom | hospital | 2 | 2 | 31 Aug 2026 |
| Belgium | public | 1 | 1 | 01 Sep 2026 |
| Greece | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.